ArticleLung Cancer (Auckland, N.Z.)2024

Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea.

Joo Sung Shim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.